The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 13.00
Ask: 14.00
Change: 0.50 (3.85%)
Spread: 1.00 (7.692%)
Open: 13.50
High: 14.00
Low: 13.50
Prev. Close: 13.00
ESYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Sep 2022 10:27

RNS Number : 7731Z
essensys PLC
16 September 2022
 

16 September 2022

 

essensys plc

("essensys" or the "Group")

Grant of Options

essensys plc, the leading global provider of mission-critical software and technology to the flexible workspace industry, announces that its has granted options over a total of 1,031,287 options under the Group's existing Long-Term Incentive Plan (the "LTIP") to certain members of its executive management team as follows:

Name

Position

Number of Options

Alan Pepper

Chief Operating Officer

204,636

Sarah Harvey

Chief Financial Officer

366,667

Jeremy Bernard

CEO, North America

120,000

James Lowery

CEO, UK & Europe

120,000

David Kinnaird

Chief Customer Officer

104,876

James Shannon

Chief Product & Technology Officer

115,108

These grants are all subject to performance conditions, have an exercise price of 0.25 pence per share and will, depending on the individual concerned, become exerciseable between November 2023 and November 2025.

Mark Furness, Chief Executive Officer of the Group, has waived his entitlement to the planned option grant set out in the Group's Annual Report for the year ended 31 July 2021 and, in order to minimise dilution of existing shareholders' positions, has indicated that he will waive any entitlement to option grants for the foreseeable future.

In respect of Alan Pepper this grant replaces the previously reported planned grant as was set out in the Remuneration Committee Report included within the Group's Annual Report for the year ended 31 July 2021. Sarah Harvey's grant is in relation to her commencement of employment as the Group's Chief Financial Officer.

At the same time the Remuneration Committee has agreed to extend the vesting period for LTIP options with performance conditions issued on 28 May 2019 (immediately prior to the Group's IPO and as set out in the Group's Admission Document) to 28 May 2024. This is intended to ensure that the optionholders' interests in the improvement in the Group's share price remain aligned to those of our shareholders.

Following these grants, the Group has a total of 4,375,163 share options outstanding, representing 6.8% of the existing issued share capital of the Group.

For further information, please contact:

essensys plc

+44 (0)20 3102 5252

Mark Furness (Chief Executive Officer)Alan Pepper (Chief Operating Officer)Sarah Harvey (Chief Financial Officer)

Singer Capital Markets (nominated adviser and broker)

+44 (0)20 7496 3000

Peter Steel / Harry Gooden / George Tzimas

FTI Consulting (public relations adviser)

+44 (0)20 3727 1000

Jamie Ricketts / Eve Kirmatzis / Talia Jessener / Victoria Caton

About essensys plc

essensys is the leading global provider of mission-critical SaaS platforms and on-demand cloud services to the high growth flexible workspace industry. essensys' software is specifically designed and developed to help solve the complex operational challenges faced by multi-site flexible workspace operators as they grow and scale their operations. The Group's technology allows operators to deliver a range of differentiated, flexible and customer-specific services to a broad base of tenants across multiple locations and helps operators to manage the cost, operational and technological challenges they typically encounter.

The essensys Platform addresses these complex operational challenges, and reduces costs by simplifying the day-to-day management of flexible workspaces and the provision of on-demand IT, technology and infrastructure services to tenants. essensys' platforms automate key tasks and processes and help flexible workspace providers deliver highly efficient, customer-centric workspace solutions and member experiences with enterprise class services.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

1. Alan Pepper

2. Sarah Harvey

3. Jeremy Bernard

4. James Lowery

5. David Kinnaird

6. James Shannon

2

 

Reason for the notification

 

a)

 

Position/status

 

1. Chief Operating Officer

2. Chief Financial Officer

3. CEO, North America

4. CEO, UK & Europe

5. Chief Customer Officer

6. Chief Product & Technology Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

essensys PLC

b)

 

LEI

 

2138002MSI4WKYNOBS73

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares

Identification code

GB00BJL1ZF49

b)

 

Nature of the transaction

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

0.25 pence

1. 204,636

2. 366,667

3. 120,000

4. 120,000

5. 104,876

6. 115,108

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

15 September 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUAPBUPPUBQ
Date   Source Headline
30th Apr 20247:00 amRNSHalf year results
19th Apr 20249:00 amRNSNotice of Results
11th Jan 20247:00 amRNSBoard Change
7th Dec 202310:39 amRNSResult of AGM
23rd Nov 20237:00 amRNSIssue of Equity and Total Voting Rights
8th Nov 20237:00 amRNSPosting of 2023 Annual Report and Notice of AGM
31st Oct 20237:00 amRNSFull year results
23rd Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
19th Oct 20237:00 amRNSNotice of Results
6th Sep 20237:00 amRNSIssue of Equity and Total Voting Rights
31st Aug 20237:00 amRNSFull year trading update
4th Jul 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Mar 20237:00 amRNSHalf year results
22nd Mar 202311:30 amRNSNotice of Results and Investor Presentation
28th Feb 20237:00 amRNSHalf Year Trading Update
6th Dec 20229:37 amRNSHolding(s) in Company
1st Dec 202212:04 pmRNSResult of AGM
1st Dec 20227:00 amRNSAGM Trading Update
7th Nov 20224:00 pmRNSPosting of 2022 Annual Report and Notice of AGM
1st Nov 20227:00 amRNSPublication of Audited Annual Report and Accounts
18th Oct 20227:00 amRNSFULL YEAR RESULTS
14th Oct 20227:00 amRNSNotice of Investor Presentation
26th Sep 20229:30 amRNSNotice of Results
16th Sep 202210:27 amRNSDirector/PDMR Shareholding
24th Aug 20227:00 amRNSFull Year Trading Update
17th May 20227:00 amRNSBoard Changes
9th May 20229:52 amRNSHolding(s) in Company
3rd May 20223:18 pmRNSDirector/PDMR Shareholding
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20229:05 amRNSSecond Price Monitoring Extn
21st Apr 20229:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSHalf-year Report
29th Mar 20227:00 amRNSNotice of Investor Meet Company Presentation
22nd Mar 202210:46 amRNSHolding(s) in Company
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:56 pmRNSDirector/PDMR Shareholding
11th Mar 202210:08 amRNSNotice of Results
10th Mar 202212:31 pmRNSHolding(s) in Company
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSTrading Update
7th Feb 20227:00 amRNSAppointment of CEO UK & Europe and PDMR Dealing
3rd Feb 20227:00 amRNSBoard Changes
2nd Dec 202111:20 amRNSResult of AGM
16th Nov 20212:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.